In late January, the Department of Justice (DOJ) under Trump sued to block Hewlett Packard Enterprise from acquiring Juniper Networks in a $14 billion deal. The DOJ alleged that the acquisition, which ...

Mutual of America Capital Management LLC trimmed its position in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 2.6% during the ...

S&P 500 E-Mini futures (ESH25) are down -0.92%, and March Nasdaq 100 E-Mini futures (NQH25) are down -1.14% this morning as higher Treasury yields, trade war worries, and disappointing tech earnings ...

One manager, Steve Cohen's Point72, has a waitlist of $9 billion to get into its funds.

We recently published a list of the 10 Best Vaccine Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Goldman Sachs warned there's a risk of a 5% slump in US stocks because ... retreated after President Trump imposed an additional 10% tariff on Chinese goods. Moderna (MRNA) closed down more than -7% ...

Donald Trump appears to have secured David Solomon’s job for the foreseeable future. The Goldman Sachs CEO has had, let’s say, a rocky relationship with the rank-and-file inside the big ...

If imposed, these tariffs could have a 0.1-0.6 percent impact on India's GDP, global investment firm Goldman Sachs forecasted. Goldman Sachs outlined three potential ways Trump's reciprocal ...

Rep. Dan Goldman (D-N.Y.), who served as lead counsel in President Trump’s first impeachment, said Wednesday that he thinks the president has committed “dozens of impeachable offenses” since ...

Goldman Sachs said that the “reciprocal tariff” plan is expected to impact India in three ways. (Photo source: PTI) With US President Donald Trump announcing that the country will likely ...

In an interview with Scripps News, Rep. Dan Goldman, D-New York, expressed strong concerns about President Donald Trump's recent executive order that places independent government agencies under the ...

MRNA has been the topic of several other reports. The Goldman Sachs Group downgraded Moderna from a “buy” rating to a “neutral” rating and reduced their target price for the stock from $99 ...